Search results
Results from the WOW.Com Content Network
He supports federal funding for embryonic stem cell research on the already existing lines of approximately $100 million, $250 million for research on adult and animal stem cells, and creates the President's Council on Bioethics led by Dr. Leon Kass of the University of Chicago to "monitor stem cell research, to recommend appropriate guidelines ...
The Southern Baptist Convention opposes human embryonic stem cell research on the grounds that the "Bible teaches that human beings are made in the image and likeness of God (Gen. 1:27; 9:6) and protectable human life begins at fertilization." [71] However, it supports adult stem cell research as it does "not require the destruction of embryos ...
In response to allegations of irregularities in Obokata's research publications involving STAP cells, Riken launched an investigation that discovered examples of scientific misconduct on the part of Obokata. Attempts to replicate Obokata's STAP cell results failed. The ensuing STAP cell scandal gained worldwide attention.
[13] [21] The research, published in the 12 March 2004 issue of Science, was reported as "Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst." [ 22 ] For its potential medical value to replace diseased and damaged cells, several scientists had previously tried to clone the human embryo, but in vain. [ 23 ]
The composition of ESCRO committees was specified to include representatives of the public and people with expertise in developmental biology, stem cell research, molecular biology, assisted reproduction, and ethical and legal issues in human embryonic stem cell research.
In June 2000, Venter founded The Center for the Advancement of Genomics (TCAG), a think tank for studying the ethics of human genetics and stem cells research. [ 19 ] [ 20 ] Also in 2002, Venter founded the Institute for Biological Energy Alternatives (IBEA) to investigate the use of microorganisms to produce alternate fuels (such as hydrogen ...
Our research group has pioneered methods to turn these stem cells into miniature heart tissues that can be used to model disease-in-a-dish, to identify new drug targets for the development of new ...
In 1998, Thomson's Lab was the first to report the successful isolation of human embryonic stem cells. On November 6, 1998, Science published this research in an article titled "Embryonic Stem Cell Lines Derived from Human Blastocysts", results which Science later featured in its “Scientific Breakthrough of the Year” article, 1999. [3]